Pulmonary Hypertension Trial, Recruiting NCT03959748 Sponsor: Polish Cardiology Association Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT03959748
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with pulmonary arterial hypertension (a type of high blood pressure affecting the lungs) or chronic thromboembolic pulmonary hypertension (lung high blood pressure caused by blood clots) after 1st March 2018, who are older than 3 months at the time of joining the trial
  • People diagnosed with either of these conditions after 1st March 2018, whose heart and lung pressure measurements meet specific levels recorded during a specialised heart test (confirm with trial site for exact values)
  • People diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension before 1st March 2018, who are older than 3 months at the time of joining the trial
  • People diagnosed with either of these conditions before 1st March 2018, whose heart and lung pressure measurements meet specific levels recorded during a specialised heart test (confirm with trial site for exact values)

Who may not be able to join:

  • People who do not have a confirmed diagnosis of pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
  • People who are 3 months old or younger at the time of enrollment
  • People whose heart and lung pressure measurements do not meet the specific levels required by the trial (confirm with trial site for exact values)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Grzegorz Kopeć, MD, Phd, Krakowski Szpital Specjalistyczny im. Jana Pawła II

Phone: +48 12 614 33 99

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Polish Cardiology Association
Registry
ClinicalTrials.gov
Start date
1 March 2018
Est. completion
28 February 2023

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov